Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study Of Adjuvant Fluourouracil, Epirubicin And Cyclophosphamide, In Women With Stage I Breast Cancer

NCT00055679 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00055679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00055679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study Of Adjuvant Fluourouracil, Epirubicin And Cyclophosphamide, In Women With Stage I Breast Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2002
Completion date
June 30, 2013
Enrollment
1,512 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer